What is Corcept Therapeutics Inc.'s Market Cap?

Corcept Therapeutics Inc.'s Market Cap is $9.3B, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Enterprise Value?

Corcept Therapeutics Inc.'s Enterprise Value is $9.0B, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Trailing P/E?

Corcept Therapeutics Inc.'s Trailing P/E is 168.2×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Price / Sales?

Corcept Therapeutics Inc.'s Price / Sales is 11.2×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EV / Revenue?

Corcept Therapeutics Inc.'s EV / Revenue is 10.8×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EV / EBITDA?

Corcept Therapeutics Inc.'s EV / EBITDA is 1110.0×, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Revenue (TTM)?

Corcept Therapeutics Inc.'s Revenue (TTM) is $830.8M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Net Income (TTM)?

Corcept Therapeutics Inc.'s Net Income (TTM) is $55.2M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s EBITDA?

Corcept Therapeutics Inc.'s EBITDA is $8.1M, based on as-reported figures from SEC (XBRL) filings.

What is Corcept Therapeutics Inc.'s Diluted EPS (TTM)?

Corcept Therapeutics Inc.'s Diluted EPS (TTM) is 0.51, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Corcept Therapeutics Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S8QGV1

85.86▼ 21.64 (-20.13%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 107.50
Day's Range: 84.13 – 106.09
52-Week Range: 28.66 – 126.38
Volume: 2.8M
Avg Volume: 1.3M

Share Statistics

Shares Outstanding
Employees: 730
Exchange: XNAS
Listed: 2004-04-14

Share count as of July 22, 2026

Corcept Therapeutics Inc. (CORT) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Corcept Therapeutics Inc. (CORT)

What is Corcept Therapeutics Inc.'s Market Cap?: Corcept Therapeutics Inc.'s Market Cap is $9.3B, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Enterprise Value?: Corcept Therapeutics Inc.'s Enterprise Value is $9.0B, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Trailing P/E?: Corcept Therapeutics Inc.'s Trailing P/E is 168.2×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Price / Sales?: Corcept Therapeutics Inc.'s Price / Sales is 11.2×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EV / Revenue?: Corcept Therapeutics Inc.'s EV / Revenue is 10.8×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EV / EBITDA?: Corcept Therapeutics Inc.'s EV / EBITDA is 1110.0×, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Revenue (TTM)?: Corcept Therapeutics Inc.'s Revenue (TTM) is $830.8M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Net Income (TTM)?: Corcept Therapeutics Inc.'s Net Income (TTM) is $55.2M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s EBITDA?: Corcept Therapeutics Inc.'s EBITDA is $8.1M, based on as-reported figures from SEC (XBRL) filings.
What is Corcept Therapeutics Inc.'s Diluted EPS (TTM)?: Corcept Therapeutics Inc.'s Diluted EPS (TTM) is 0.51, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CORTAs-filed SEC (XBRL) data